In the MCF-7 model of Estrogen Receptor positive (ER+) breast cancer, treatment of cells with Tamoxifen, a selective estrogen receptor modulator (SERM), causes them to stiffen [85]. The gene discussed is ESR1; the disease is breast carcinoma.